Healthcare

Insulin pumps offer several prominent benefits over other insulin delivery methods, so why are insulin pumps so rarely used today, as compared to other insulin delivery methods?

Imagine a world where we not only upload pictures of our latest recipes, beauty products, and coffees - but also share their smell. The opportunities for digital smell could be vast, but what are they, and what gas sensor technology will enable it?

Thursday 23 June 2022 - Mass-digitization trend is predicted to cause the gas sensor market to surpass $8 billion by 2032. The gas sensor market is a complex combination of multiple technologies and applications - and understanding where true opportunities for commercial success exist is challenging.

Air quality concerns are on the rise globally, with urban pollution the dominant cause. However, radon accumulation and unpleasant aromas are often bigger problems in rural locations, creating opportunities for gas sensors that offer continuous monitoring and even odor categorization.

COVID-19 testing at point of care peaked in Q1 2022. Is testing waning? What is COVID-19's lasting effect on point-of-care testing?

Gas sensors are simultaneously an established and emerging industry, creating a complex web of technologies and applications for stakeholders to understand. Detection methods span a diverse technology landscape, ranging from semiconductor and optical to acoustic and photoionization.

Glucose monitoring is an integral part of diabetes management, and test strips have historically been the predominant method of measuring blood glucose. However, continuous glucose monitors (CGMs) have emerged as a major competitor over the last decade.

Thursday 5 May 2022 - What is driving the growing need for point-of-care? Is point-of-care too expensive? What's next for COVID-19 point-of-care? The webinar will discuss growth during the COVID-19 pandemic; the market beyond COVID-19; key trends; and emerging transduction methods at point-of-care

Never before has point-of-care testing been so crucial to healthcare systems. In the last 2 years, COVID-19 has caused the point-of-care biosensors industry to expand by almost 300%. A recent IDTechEx report explains the drivers causing the shift from conventional laboratory-based diagnostics toward point-of-care diagnostics performed directly at hospitals, clinics, offices, and at home.

By the year 2032, IDTechEx predicts the test strip industry to make up only 6.7% of the overall diabetes management device market, down from a peak of 63.4% in 2010.